Skip to main content
Quest Diagnostics

Two Copies, One Condition? Understanding APOE Allele State in over 14,000 Symptomatic Patients

ACMG Annual Clinical Genetics meeting 2025

American College of Medical Genetics

Los Angeles, CA, Mar 18-21 , 2025

Poster presentation: Two Copies, One Condition? Understanding APOE Allele State in over 14,000 Symptomatic Patients

Authors: Powis Z, Liaquat K, Basran R, Wang Z

Specialty: Genetics, Neurology

Related content

Publication
EXPRESS: New Plasma LC-MS/MS Assays for the Quantitation of Beta-amyloid Peptides and Identification of Apolipoprotein E Proteoforms for Alzheimer’s Disease Risk Assessment
Publication
Clinical Utility of Plasma Aβ42/40 Ratio by LC-MS/MS in Alzheimer’s Disease Assessment
Test FAQ
Quest Dementia Testing
On-Demand Webinar
Revolutionizing Alzheimer’s Disease Clinical Trials Using a Blood-Based Diagnostic Test for Participant Identification
Audio Podcast
Assessing for Alzheimer’s Disease with Quest Diagnostics
Audio Podcast
Patient-minded Neurology
Publication
Diffusion MRI Relates to Plasma Aβ42/40 in PET Negative Participants Without Dementia

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.